youtube_live
Utili Q3 2026 • pubblicata • Utili per azione superati +8,62% • Fatturato superato +2,31%
Esamina i risultatichevron_right
EW:NYSE
Edwards Lifesciences
99,37 USD
arrow_upward
+4,38%(+4,17) 1G
103,00 USD
arrow_upward
+3,65% (+3,63)bedtimeAfter Hours
Chiusura: 4 nov, 16:00:04 GMT-5 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per EW in corso…
Apertura
98,58 USD
Massimo
100,25 USD
Minimo
96,72 USD
Cap. mercato
57,28 Mld
Vol. medio
4,00 Mln
Volume
7,90 Mln
Rapporto P/E
57,49
Max 52 sett.
100,25 USD
Min 52 sett.
74,66 USD
Utili per azione
1,73 USD
Beta
0,85
Azioni in circolazione
576,40 Mln
N. di dipendenti
16K
Apertura
98,58 USD
Massimo
100,25 USD
Minimo
96,72 USD
Cap. mercato
57,28 Mld
Vol. medio
4,00 Mln
Volume
7,90 Mln
Rapporto P/E
57,49
Max 52 sett.
100,25 USD
Min 52 sett.
74,66 USD
Utili per azione
1,73 USD
Beta
0,85
Azioni in circolazione
576,40 Mln
N. di dipendenti
16K
Articoli giornalistici
Da fonti web e partner giornalistici
BigGo Finance
·
6 ore fa
[Edwards Lifesciences Q3 2026 Earnings Call] Edwards Raises Full-Year Guidance to 11.5% Sales Growth and $3.01 EPS Midpoint After Q3 Beat; TAVR Growth to Rely on Market Expansion, Not Share Gains
GuruFocus
·
7 ore fa
Edwards Lifesciences (EW) Q3 Earnings Beat Expectations, Raises Guidance
Benzinga
·
8 ore fa
Edwards Lifesciences Q3 2026 Earnings Call Transcript
Investing.com
·
8 ore fa
Edwards Lifesciences earnings beat by $0.06, revenue topped estimates
Profilo
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Informazioni su Edwards Lifesciences
CEO-
Dipendenti16K
Data di fondazione1958
SedeIrvine, California, Stati Uniti
Settore-
Industry-
Sito webedwards.com